Similar articles

• Clozapine treatment and neuroleptic malignant syndrome.

  Doan RJ, Callaghan WD. Doan RJ, et al. Can J Psychiatry. 2000 May;45(4):394-5. Can J Psychiatry. 2000. PMID: 10813077 No abstract available.
• Clozapine-induced neuroleptic malignant syndrome and subdural hematoma.

  Duggal HS. Duggal HS. J Neuropsychiatry Clin Neurosci. 2004 Winter;16(1):118-9. doi: 10.1176/jnp.16.1.118. J Neuropsychiatry Clin Neurosci. 2004. PMID: 14990770 No abstract available.
• Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.

  Illing M, Ancill R. Illing M, et al. Can J Psychiatry. 1996 May;41(4):258. Can J Psychiatry. 1996. PMID: 8726793 No abstract available.
• Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.

  Hasan S, Buckley P. Hasan S, et al. Am J Psychiatry. 1998 Aug;155(8):1113-6. doi: 10.1176/ajp.155.8.1113. Am J Psychiatry. 1998. PMID: 9699705 Review.
• Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.

  Sachdev P, Kruk J, Kneebone M, Kissane D. Sachdev P, et al. J Clin Psychopharmacol. 1995 Oct;15(5):365-71. doi: 10.1097/00004714-199510000-00010. J Clin Psychopharmacol. 1995. PMID: 8830069 Review.